[SCHEDULE 13G/A Amendment No. 14 Global Cord Blood Corporation (Name of Issuer) Common Stock, par value $0.0001 per share (Title of Class of Securities) 698659109 (CUSIP Number) December 31, 2018 (Date of Event Which Requires Filing of this Statement) ☐ Rule 13d-1(b) ☒ Rule 13d-1(c) ☐ Rule 13d-1(d) *]
[Joint Filing Agreement 13d-1(k) In accordance with Rule [Remainder of this page has been left intentionally blank.] 16 Sheng Chen Sheng Chen Fast Horse Technology Limited Sheng Chen Director Sunrise Corporate Holding Ltd. Sheng Chen Director Personal Group Limited Sheng Chen Director Beacon Capital ]
[Joint Filing Agreement 13d-1(k) In accordance with Rule [Remainder of this page has been left intentionally blank.] 16 Sheng Chen Sheng Chen Fast Horse Technology Limited Sheng Chen Director Sunrise Corporate Holding Ltd. Sheng Chen Director Personal Group Limited Sheng Chen Director Beacon Capital ]
[Fanhua Employees Holdings Limited 2 Check the Appropriate Box if a Member of a Group (a) (b) 3 SEC Use Only 4 Citizenship or Place of Organization British Virgin Islands Number of Shares Beneficially Owned by Each Reporting Person With 5 Sole Voting Power 200,000,000 6 Shared Voting Power 0]
[CUSIP No. 89977P106 Page 2 of 7 1 NAMES OF REPORTING PERSONS Temasek Holdings (Private) Limited 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS) (a) ☐ (b) ☐ 3 SEC USE ONLY 4 CITIZENSHIP OR PLACE OF ORGANIZATION Republic of Singapore NUMBER OF SHARES BENEFICIALLY OWNED BY EACH RE]
[(1) This CUSIP number applies to the Issuers American depositary shares, each representing 25 ordinary shares. CUSIP No. 64110W102 13G]
